18-31521244-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 9P and 4B. PVS1PP5BS2
The NM_001943.5(DSG2):c.523+1G>C variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000106 in 1,602,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001943.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSG2 | NM_001943.5 | c.523+1G>C | splice_donor_variant, intron_variant | ENST00000261590.13 | NP_001934.2 | |||
DSG2 | XM_047437315.1 | c.-12+1G>C | splice_donor_variant, intron_variant | XP_047293271.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSG2 | ENST00000261590.13 | c.523+1G>C | splice_donor_variant, intron_variant | 1 | NM_001943.5 | ENSP00000261590.8 |
Frequencies
GnomAD3 genomes AF: 0.00000663 AC: 1AN: 150808Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000126 AC: 3AN: 238030Hom.: 0 AF XY: 0.0000232 AC XY: 3AN XY: 129154
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1451740Hom.: 0 Cov.: 32 AF XY: 0.0000180 AC XY: 13AN XY: 721696
GnomAD4 genome AF: 0.00000663 AC: 1AN: 150894Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73624
ClinVar
Submissions by phenotype
Cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Mar 30, 2020 | - - |
Arrhythmogenic right ventricular dysplasia 10 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 01, 2022 | ClinVar contains an entry for this variant (Variation ID: 188450). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Disruption of this splice site has been observed in individuals with arrhythmogenic right ventricular cardiomyopathy (PMID: 27532257, 30790397; Invitae). This variant is present in population databases (rs553299589, gnomAD 0.01%). This sequence change affects a donor splice site in intron 5 of the DSG2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DSG2 are known to be pathogenic (PMID: 17105751, 31386562). - |
Arrhythmogenic right ventricular dysplasia 10;C2752072:Dilated cardiomyopathy 1BB Pathogenic:1
Pathogenic, no assertion criteria provided | research | Donald Williams Parsons Laboratory, Baylor College of Medicine | Sep 17, 2014 | This splice site variant is categorized as deleterious according to ACMG guidelines (PMID:18414213). It was an incidental finding in our study, in a 4-year-old female with mixed neuroglial tumor. - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 05, 2024 | The c.523+1G>C intronic variant results from a G to C substitution one nucleotide after coding exon 5 of the DSG2 gene. This variant has been reported in an individual indicated as having arrhythmogenic right ventricular cardiomyopathy, but clinical details were limited (Bourfiss M et al. Circ Genom Precis Med, 2022 Dec;15:e003704). Another alteration affecting this nucleotide (c.523+1G>A) was detected in a cohort referred for arrhythmogenic right ventricular cardiomyopathy (ARVC) genetic testing, and was also detected in a sudden cardiac arrest cohort (Walsh R et al. Genet. Med., 2017 02;19:192-203; Mellor G et al. Circ Cardiovasc Genet, 2017;10:e001686). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site and may result in the creation or strengthening of a novel splice donor site. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic. - |
Arrhythmogenic right ventricular cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Aug 06, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at